Cytovale

Cytovale started with an obvious question: Why do so many people die every year from sepsis?

Part of the answer is that sepsis, like many acute diseases, is incredibly fast moving and devastating. The other part of the answer is that, until now, diagnosis just took too long for critical care providers to intervene in time. So like all diligent life scientists, Cytovale started asking themselves even more questions: How many lives would they help save if we could diagnose diseases faster? Is there a different way? What are they not seeing?

What followed is over a decade of insatiable curiosity, collaborative research, and determined development to diagnose disease by unlocking immune state in real time to redefine the patient journey.

At Cytovale, they are an extraordinary team of biologists, data scientists, engineers, former care providers, financiers, and just plain caring people with a vision for how to make very complex, critical diseases come into sharp and present focus. And that’s why Cytovale will never stop working together, striving to make their technology stronger, faster, and easier-to-implement so that every person who arrives for medical care is quickly screened and appropriately treated for fast-moving diseases while there is still time to act.